DAFTAR PUSTAKA
Al-Maskari, F., El-Sadig, M., Nagelkerke, N., 2010, Assessment of the Direct Medical Costs of Diabetes Mellitus and its Complications in the United Arab Emirates, BMC Public Health, 1-10.
Amalia, Andayani, T.M., Yuniarti, E., 2015, Hubungan Komplikasi Diabetes Melitus terhadap Biaya Terapi, Jurnal Manajemen dan Pelayanan Farmasi, 5 (3), 159-170.
American Diabetes Association, 2013, Economic Costs of Diabetes in the U.S. in 2012, Diabetes Care 2013, 36 (4), 1033-1046.
American Diabetes Association, 2017, American Diabetes Association : Standards of Medical Care in Diabetes-2017, the American Diabetes Association, USA.
Andayani, T.M., 2013, Farmakoekonomi: Prinsip & Metodologi, Bursa Ilmu, Yogyakarta.
Bahia, L.R., Araujo, D. V., Schaan, B.D., Dib, S.A., Negrato, C.A., Leao, M.P.S., Ramos, A.J.S., Forti, A.C., Gomes, M.B., Foss, M.C., Monteiro, R.A., Sartorelli, D., Franco, L.J., 2011, The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health System, Value in Health, 14, S137-S140.
Baroroh, F., Solikah, W.Y., Urfiyya, Q.’A., 2016, Analisis Biaya Terapi Diabetes Melitus Tipe 2 di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta, Jurnal Farmasi Sains dan Praktis, 1 (2), 11-22.
Byford, S., Torgerson, D.J., Raftery, J., 2000, Economic Note Cost of Illness Studies, BMJ 2000, 320:1335.
BPJS, 2014, INA-CBG’s Membuat Biaya Kesehatan Lebih Efektif, Info BPJS Kesehatan, 8, 3-4.
Caporale, J.E., Elgart, J.F., Gagliardino, J.J., 2013, Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy, Globalization and Health, 9(25), 1-10.
Dinaryanti, P., 2012, Analisis Biaya dan Efektivitas Terapi Pasien Diabetes Melitus Tipe 2 Rawat Jalan di RSUD Sleman Yogyakarta, Jurnal Manajemen dan Pelayanan Farmasi, 2 (1), 14-19.
Ekpenyong, C.E., Akpan, U.P., Ibu, J.O., Nyebuk, D.E., 2012, Gender and Age Specific Prevalence and Associated Risk Factors of Type 2 Diabetes
Mellitus in Uyo Metropolis, South Eastern Nigeria, Department of Physiology, College of Health Sciences, University of Uyo, Akwa Ibom State, Nigeria, 17-28.
Elsevier’s Point of Care Editorial Team, 2018, Clinical Overview : Diabetes Mellitus Type 2 in Adults, Elsevier Point of Care.
Fitri, E., Andayani, T.M., Suparniati, E., 2015, Analisis Biaya Penyakit Diabetes Melitus, Jurnal Manajemen dan Pelayanan Farmasi, 5 (1), 61-66.
Fowler, M.J., 2008, Microvascular and Macrovascular Complications of Diabetes, Clinical Diabetes, 26(2), 77-82.
Hartanto, D. & Mulyani, T., 2017, Gambaran Biaya Pasien Diabetes Melitus Tipe 2 dengan Terapi Antidiabetik Oral di RSUD Ulin Banjarmasin, Jurnal Ilmiah Ibnu Sina, 2 (1), 109-116.
Henriksson, F., Agardh, C.D., Berne, C., Bolinder J., Lonngvist F., Stenstrom, P., Ostenson, CG., Jonsson, B., 2000, Direct Medical Costs for Patients with Type 2 Diabetes in Sweden, NCBI, 248(5):387-96.
International Diabetes Federation, 2015, IDF Diabetes Atlas, Seventh Edition, http://www.diabetesatlas.org/, 24 Mei 2017.
Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A.L., Tsapas, A., Wender, R., Matthews, D.R., 2012, Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach, Diabetes Care, Volume 35, 1364-1379.
Janigian, R.H., 2018, Diabetic Retinopathy, Ferri’s Clinical Advisor 2018, 392- 392.e3.
Kementerian Kesehatan RI, 2005, Pharmaceutical Care untuk Penyakit Diabetes Mellitus, 22-25, Direktorat Bina Farmasi Komunitas dan Klinik Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan Departemen Kesehatan RI, Jakarta.
Kementerian Kesehatan RI, 2013a, Buku Pegangan Sosialisasi Jaminan Kesehatan Nasional (JKN) dalam Sistem Jaminan Sosial Nasional, 9-10, 16, 27, Kementerian Kesehatan RI, Jakarta
Kementerian Kesehatan RI, 2013b, Pedoman Penerapan Kajian Farmakoekonomi, Kementerian Kesehatan RI, Jakarta.
Kementerian Kesehatan RI, 2014a, INFODATIN : Pusat Data dan Informasi Kementerian Kesehatan RI, Kementerian Kesehatan RI, Jakarta.
Kementerian Kesehatan RI, 2014b, Peraturan Menteri Kesehatan Republik Indonesia Nomor 27 Tahun 2014 tentang Petunjuk Teknis Sistem Indonesian Case Base Groups (INA-CBGs), Kementerian Kesehatan RI, Jakarta.
Kementerian Kesehatan RI, 2016, Peraturan Menteri Kesehatan Republik Indonesia Nomor 52 Tahun 2016 tentang Standar Pelayanan Kesehatan dalam Penyelenggaraan Program Jaminan Kesehatan, Kementerian Kesehatan RI, Jakarta.
Klein, S. & Romijn, J.A., 2016, Obesity, Williams Textbook of Endocrinology, Thirteenth Ed., 36:1633-1659.
Lemeshow, S., Hosmer Jr, D.W., Klar, J., Lwanga, S.K., 1990, Adequacy of Sample Size in Health Studies, 1-2, John & Sons Ltd, England.
Litwak, L., Goh, S., Hussein, Z., Malek, R., Khamseh, M.E., 2013, Prevalence of Diabetes Complications in People with Type 2 Diabetes Mellitus and Its Association with Baseline Characteristics in the Multinational A1chieve Study, Diabetology & Metabolic Syndrome, 5:57.
Morrish, N.J., Wang, S.L., Stevens, L.K., Fuller, J.H., Keen, H., 2001, Mortality and Causes of Death in the WHO Multinational Study of Vascular Disease in Diabetes, NCBI, 44, 14-21.
Mursalin & Soewondo, P., 2016, Analisis Estimasi Biaya Langsung Medis Penderita Rawat Jalan Diabetes Mellitus Tipe 2 di RSUD Dr. Abdul Aziz Singkawang, Jurnal Ekonomi Kesehatan Indonesia, 1 (2), 1-12.
PERKENI, 2015, Konsensus Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 di Indonesia 2015, PB. PERKENI, Jakarta.
Price, S.A. & Wilson, L.M., 2006, Patofisiologi : Konsep Klinis Proses-Proses Penyakit, Edisi 6, 1264-1270, Penerbit Buku Kedokteran EGC, Jakarta.
Queally, M. B., 2013, A Cost Analysis of Medication for Patients with Type 2 Diabetes Mellitus (T2DM)-How Varies According to Body Mass Index (BMI) Status, Age, Gender and Co-Morbidity, Value in Health, 16 (7), A437-A437.
Riewpaiboon, A., Pornlertwadee, P., Pongsawat, K., 2007, Diabetes Cost Model of a Hospital in Thailand, Journal Value Health, 10 (4), 223-230.
Sanchez, Lisa A., 2011, Pharmacoeconomics: Principles, Methods, and Applications dalam DiPiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R.,
Wells, B.G., Posey, L. M., Pharmacotherapy: A Pathophysiologic Approach, McGraw-Hill, New York.
Sari, R.P., 2014, Perbandingan Biaya Riil dengan Tarif Paket INA-CBGs dan Analisis Faktor yang Mempengaruhi Biaya Riil pada Pasien Diabetes Melitus Rawat Inap Jamkesmas di RSUP dr. Sardjito Yogyakarta, Jurnal Spread, 4 (1), 61-70.
Setyawan, I.A., 2016, Karakteristik Terapi dan Analisis Biaya Penyakit Stroke Perdarahan di Rumah Sakit Bethesda Yogyakarta, Tesis, Program Pascasarjana Fakultas Studi Ilmu Farmasi Universitas Gadjah Mada, Yogyakarta.
Schmiit-Koopmann, I., Schwenkglenks, M., Spinas, G.A., Szucs, T.D., 2004, Direct Medical Costs of Type 2 Diabetes and Its Complications in Switzerland, European Journal Public Health, 14, 3–9.
Shuyu Ng, C., Toh, M.P.H.S., Ko, Y., Yu-Chia Lee, J., 2015, Direct Medical Cost of Type 2 Diabetes in Singapore, PloS One, 10 (3), e0122795.
Struijs, J.N., Baan, C.A., Schellevis, F.G., Westert, G.P., Bos, G.A.M.V.D., 2006, Comorbidity in Patients with Diabetes Mellitus : Impact on Medical Health Care Utilization, BMC Health Services Research, 1-9.
Tandra, H., 2017, Segala Sesuatu yang Harus Anda Ketahui Tentang Diabetes:
Panduan Lengkap Mengenal dan Mengatasi Diabetes dengan Cepat dan Mudah, Edisi Kedua, 64-75, 212, 222-227, PT Gramedia, Jakarta.
Tjokroprawiro, H. A., 1986, Diabetes Mellitus : Aspek Klinik dan Epidemiologi, Airlangga University Press, Surabaya.
Walikota Yogyakarta, 2017, Peraturan Walikota Yogyakarta Nomor 27 tahun 2017 tentang Penyelenggaraan Jaminan Kesehatan Daerah, Walikota Yogyakarta, Yogyakarta.
Wells, B.G., Dipiro, J.T., Schwinghammer, T.L., Dipiro, C.V., 2009, Pharmacotherapy Handbook, Seventh Edition, 210, McGraw-Hill, New York.
WHO, 1982, Provisional Guidelines on Standard International Age Classification, 8, United Nations Publication, New York.
Wu, Y., Ding, Y., Tanaka, Y., Zhang, W., 2014, Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention, International Journal of Medical Sciences, 11 (11), 1185-1200.
Zhuo, X., Zhang, P., Hoerger, T.J., 2013, Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications, American Journal of Preventive Medicine, 45 (3), 253-261.
